Implanet S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMPZY research report →
About the company
Implanet S. A. , along with its affiliated entities, focuses on the creation, production, and distribution of medical implants for both spinal and orthopedic applications.
- CEO
- Ludovic Lastennet
- IPO
- 2017
- Employees
- 40
- HQ
- Martillac, FR
Price Chart
- Market Cap
- $230.11M
- P/E
- -6.43
- P/S
- 1.96
- P/B
- 69.76
- EV/EBITDA
- -9.80
- Div Yield
- 0.00%
- Gross Margin
- 50.30%
- Op Margin
- -43.71%
- Net Margin
- -35.13%
- ROE
- 912.92%
- ROIC
- -83.21%
- Revenue
- $12.47M · 32.62%
- Net Income
- $-4,382,000 · -0.37%
- EPS
- $-0.00 · 22.73%
- Op Income
- $-3,928,000
- FCF YoY
- 23.52%
- 52W High
- $0.08
- 52W Low
- $0.08
- 50D MA
- $0.08
- 200D MA
- $0.08
- Beta
- 0.61
- Avg Volume
- 4.06K
Get TickerSpark's AI analysis on IMPZY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our IMPZY coverage
Recent articles, reports, and earnings notes.
No research on IMPZY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IMPZY report →Similar companies
Peers in the same neighborhood.